LAG3 and neoplasm: Of equal importance are the MHCII molecules, which also display tumor or pathogen-derived antigens, as on APCs such as dendritic cells, or macrophages, and which subsequently bind the LAG-3 ligand on activated T cells and NK cells, and inhibit their activation [197, 198].